Experts weigh benefits and risks of testosterone therapy
Միայն փաստեր

Experts weigh benefits and risks of testosterone therapy

Ամփոփում

Medical researchers say testosterone replacement can help people with clinically low levels, but evidence does not support routine use for healthy adults and supplements lack proven efficacy.

A growing public interest in testosterone has prompted scrutiny from health experts. Surveys show many men consider the hormone important to their sense of masculinity, and some are turning to supplements or prescription products to raise levels.

Testosterone is a sex hormone produced by the testes in men and by the adrenal glands and ovaries in women. It influences muscle and bone development, libido, sperm production and other functions, according to Michael Irwig, an associate professor of medicine at Harvard Medical School.

Irwig notes that the idea that higher testosterone automatically leads to better health or longer life is not supported by scientific data. For individuals diagnosed with testosterone deficiency, testosterone replacement therapy (TRT) is an FDA-approved treatment that can improve energy, sexual interest, muscle mass, bone density and red blood cell production.

Peter Snyder, a professor of medicine at the University of Pennsylvania, explains that low testosterone can result from conditions such as testicular, hypothalamic or pituitary disease, chemotherapy, HIV/AIDS, obesity and other factors.

Clinical trials, including the early-2000s TTrials and the larger 2018 TRAVERSE study, found that TRT increased sexual activity, mood, walking distance, bone density and red blood cell counts in men with low testosterone. The studies also reported potential adverse effects, such as increased arterial plaque, irregular heartbeats, certain blood clots and, unexpectedly, a higher rate of bone fractures.

Guidelines from the Endocrine Society recommend TRT only for patients with unequivocally low testosterone, typically below 300 ng/dL confirmed by multiple tests. Benefits appear strongest for men with levels under 200 ng/dL, while modestly low levels may not justify treatment.

For women, testosterone therapy may be considered for postmenopausal hypoactive sexual desire disorder, but no products are currently FDA-approved for female use.

Researchers say dietary supplements marketed to boost testosterone lack robust evidence. Irwig states that well-designed studies are absent and that supplement claims are not verified by the FDA.

Աղբյուր

Yahoo Health

Շարունակեք կարդալ — անվճար

Ստեղծեք անվճար հաշիվ՝ նորություններին հետևելու համար։ Քարտ չի պահանջվում։